Here’s the latest from GZ who was kind enough to reply to me even though I was flaming his email inbox.
On Fri, Feb 27, 2026 at 7:49?AM George Zavoico <gzavoico@nwbio.com> wrote:HI,I’ve been traveling so I’m sorry for not being prompt. But what do you want us to do? You know that no company ever provides shareholders with day to day or week to week updates on operations. We almost immediately inform everyone when a material event occurs. We provided a comprehensive update at the ASM and are making progress on all fronts. We are as frustrated as you, if not more so, by the long time it is taking the MHRA to review our MAA. The review process is ongoing, so we are being as patient as we can. If the UK Parliament can’t seem to get them to move on this, I don’t think there’s much we can do in that regard.No more travel next week, so happy to arrange a call if you’d like.Cheers, George
IMHO it is what it has always been, the MHRA is taking forever and the company is powerless to do anything to speed up the decision. This is of course disappointing, but it isn’t surprising knowing the complexity and trial complications of the treatment, the small size and lack of funding/influence of NWBO, the lack of experience and past delays of management, and the fact that the MHRA is likely controlled by large BPs like Merck who are partly owned by companies NWBO is suing like citadel.
WHAT IS SURPRISING TO ME IS THAT GZ WOULD PUBLICLY EXPRESS EXTREME FRUSTRATION WITH THE MHRA AND EVEN INVOKE THE UK PARLIAMENT BEING UNABLE TO SPEED UP THE PROCESS. IT SURE SEEMS LIKE THE MHRA IS SLOW WALKING THE MAA 🤷🏻♂️
Bullish
Market Data 
Markets 
